Welcome!

News Feed Item

Thomson Reuters Announces Nominations for Top Pharma Deals of the Year

2014 Breakthrough Awards to honor the best deal in the categories of 'Biopharmaceutical Licensing' and 'Mergers and Acquisitions'

PHILADELPHIA, April 1, 2014 /PRNewswire/ -- The Intellectual Property & Science business of Thomson Reuters, the world's leading provider of intelligent information for businesses and professionals, unveiled the nominations for the Allicense 2014 Breakthrough Awards for Deal of the Year, honoring the top global deal in each of two categories: 'Biopharmaceutical Licensing' and 'Mergers and Acquisitions' (M&A), as identified by Thomson Reuters Recap, the premier analysis tool for biopharmaceutical business deal making. The awards — to be determined by public vote — will be presented Tuesday, April 29, at Allicense, a prominent event connecting business development, licensing and M&A professionals throughout pharma, biotech and finance to discuss industry-wide challenges and collaborate on creating a roadmap for the future of pharmaceutical development.

The award nominees, five contenders in each of the two categories: Licensing and M&A, were determined by Thomson Reuters deals analysts after a thorough analysis of Recap information and other criteria that examined hundreds of deals negotiated throughout 2013. Members of the pharmaceutical community are invited to choose the top breakthrough deals in each category by submitting a ballot by end of day Friday, April 25.

"We are pleased to announce the nominees for the Allicense 2014 Breakthrough Awards for Deals of the Year and to celebrate the best in deal-making and partnering efforts that consistently drive the industry forward," said Jon Brett-Harris, managing director of Thomson Reuters Life Sciences. "It is appropriate that members of the pharmaceutical community are the final factor in determining the 2013 deals that most exemplify creative innovation."

The list of nominees includes:

LICENSING:

  • Pfizer and Lilly: tanezumb
  • OncoMed Pharmaceutical and Celgene: demcizumab and five biologics
  • Monderna Therapeutics and AstraZeneca: mRNA therapeutics for cardiometabolic, renal, and cancer targets
  • Ablynx and AbbVie: ALX-0061
  • ISIS Pharmaceuticals and Biogen Idec: Therapies for neurological diseases using Isis' antisense technology

M&A:

  • Aragon Pharmaceuticals and Johnson & Johnson: ARN-509, ARN-810; ARN-912
  • Amplimmune, Inc and  Medimmune (AstraZeneca): AMP-224, AMP-110, AMP-514
  • Okairos AG (seller) / GlaxoSmithKline (buyer): ProCvax, TerCvax
  • Lotus Tissue Repair (seller) / Shire (buyer): Recombinant collagen Type VII (rC7)
  • Trius Therapeutics (seller) / Cubist Pharmaceuticals (buyer): TR-701, GyrB/ParE

Visit the Allicense website to view in-depth details on each of the nominated deals, as well as to cast your vote for the Deal of the Year. Online voting ends on Friday, April 25, with live voting taking place at the Allicense conference until 5 p.m. PDT on Tuesday, April 29.

Allicense 2014 is the world's premier event for deal making, licensing and business development.  Industry professionals discuss key issues facing the sector and learn about innovative deals and structures of the future. Allicense 2014 takes place Tuesday, April 29, and Wednesday, April 30, in San Francisco, California. Learn more about the event and register here.  

Learn more about Thomson Reuters Recap.

Thomson Reuters
Thomson Reuters is the world's leading source of intelligent information for businesses and professionals. We combine industry expertise with innovative technology to deliver critical information to leading decision makers in the financial and risk, legal, tax and accounting, intellectual property and science and media markets, powered by the world's most trusted news organization. Thomson Reuters shares are listed on the Toronto and New York Stock Exchanges. For more information, go to www.thomsonreuters.com.

CONTACT

Jen Breen
+1 215 823 1791
jennifer.breen@thomsonreuters.com

 

Molly Malone

+1 215 823 3702

molly.malone@thomsonreuters.com

SOURCE Thomson Reuters

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
Kubernetes is an open source system for automating deployment, scaling, and management of containerized applications. Kubernetes was originally built by Google, leveraging years of experience with managing container workloads, and is now a Cloud Native Compute Foundation (CNCF) project. Kubernetes has been widely adopted by the community, supported on all major public and private cloud providers, and is gaining rapid adoption in enterprises. However, Kubernetes may seem intimidating and complex ...
While the focus and objectives of IoT initiatives are many and diverse, they all share a few common attributes, and one of those is the network. Commonly, that network includes the Internet, over which there isn't any real control for performance and availability. Or is there? The current state of the art for Big Data analytics, as applied to network telemetry, offers new opportunities for improving and assuring operational integrity. In his session at @ThingsExpo, Jim Frey, Vice President of S...
"DX encompasses the continuing technology revolution, and is addressing society's most important issues throughout the entire $78 trillion 21st-century global economy," said Roger Strukhoff, Conference Chair. "DX World Expo has organized these issues along 10 tracks with more than 150 of the world's top speakers coming to Istanbul to help change the world."
"We focus on SAP workloads because they are among the most powerful but somewhat challenging workloads out there to take into public cloud," explained Swen Conrad, CEO of Ocean9, Inc., in this SYS-CON.tv interview at 20th Cloud Expo, held June 6-8, 2017, at the Javits Center in New York City, NY.
"As we've gone out into the public cloud we've seen that over time we may have lost a few things - we've lost control, we've given up cost to a certain extent, and then security, flexibility," explained Steve Conner, VP of Sales at Cloudistics,in this SYS-CON.tv interview at 20th Cloud Expo, held June 6-8, 2017, at the Javits Center in New York City, NY.
"We provide IoT solutions. We provide the most compatible solutions for many applications. Our solutions are industry agnostic and also protocol agnostic," explained Richard Han, Head of Sales and Marketing and Engineering at Systena America, in this SYS-CON.tv interview at @ThingsExpo, held June 6-8, 2017, at the Javits Center in New York City, NY.
"We are focused on SAP running in the clouds, to make this super easy because we believe in the tremendous value of those powerful worlds - SAP and the cloud," explained Frank Stienhans, CTO of Ocean9, Inc., in this SYS-CON.tv interview at 20th Cloud Expo, held June 6-8, 2017, at the Javits Center in New York City, NY.
"Peak 10 is a hybrid infrastructure provider across the nation. We are in the thick of things when it comes to hybrid IT," explained , Chief Technology Officer at Peak 10, in this SYS-CON.tv interview at 20th Cloud Expo, held June 6-8, 2017, at the Javits Center in New York City, NY.
"We are still a relatively small software house and we are focusing on certain industries like FinTech, med tech, energy and utilities. We help our customers with their digital transformation," noted Piotr Stawinski, Founder and CEO of EARP Integration, in this SYS-CON.tv interview at 20th Cloud Expo, held June 6-8, 2017, at the Javits Center in New York City, NY.
"I think DevOps is now a rambunctious teenager – it’s starting to get a mind of its own, wanting to get its own things but it still needs some adult supervision," explained Thomas Hooker, VP of marketing at CollabNet, in this SYS-CON.tv interview at DevOps Summit at 20th Cloud Expo, held June 6-8, 2017, at the Javits Center in New York City, NY.
"We've been engaging with a lot of customers including Panasonic, we've been involved with Cisco and now we're working with the U.S. government - the Department of Homeland Security," explained Peter Jung, Chief Product Officer at Pulzze Systems, in this SYS-CON.tv interview at @ThingsExpo, held June 6-8, 2017, at the Javits Center in New York City, NY.
Everything run by electricity will eventually be connected to the Internet. Get ahead of the Internet of Things revolution and join Akvelon expert and IoT industry leader, Sergey Grebnov, in his session at @ThingsExpo, for an educational dive into the world of managing your home, workplace and all the devices they contain with the power of machine-based AI and intelligent Bot services for a completely streamlined experience.
Any startup has to have a clear go –to-market strategy from the beginning. Similarly, any data science project has to have a go to production strategy from its first days, so it could go beyond proof-of-concept. Machine learning and artificial intelligence in production would result in hundreds of training pipelines and machine learning models that are continuously revised by teams of data scientists and seamlessly connected with web applications for tenants and users.
"We're here to tell the world about our cloud-scale infrastructure that we have at Juniper combined with the world-class security that we put into the cloud," explained Lisa Guess, VP of Systems Engineering at Juniper Networks, in this SYS-CON.tv interview at 20th Cloud Expo, held June 6-8, 2017, at the Javits Center in New York City, NY.
"I will be talking about ChatOps and ChatOps as a way to solve some problems in the DevOps space," explained Himanshu Chhetri, CTO of Addteq, in this SYS-CON.tv interview at @DevOpsSummit at 20th Cloud Expo, held June 6-8, 2017, at the Javits Center in New York City, NY.